For a noble cause

Realising that there is no real platform for many people who want to contribute for the expensive treatment of those who cannot afford it, Raghuram Kote left his IT job to start the ‘Right to Live’.

It is a platform to facilitate people willing to donate for costly medical intervention of the underprivileged and lesser privileged.

“There are always people who want to contribute generously but are frustrated by the absence of a transparent platform, either private or government. That’s why we wanted to provide a larger platform that can bridge this gap and provide aid to people who can’t always afford treatment,” says Raghuram.

‘Right to Live’ brings the less privileged face-to-face with the donors, hospitals, doctors, government, charitable organisations as well as corporations.

The biggest advantage is perhaps the fact that donors are assured that they are indeed contributing to a genuine cause.

So how does the organisation keep this process transparent?

Raghuram says, “It’s purely based on recommendation. We take in patients who come to us via known NGOs. Often some doctors refer the cases to us and we follow it
up with a field survey by one of our programme co-ordinators – this is to assess the genuineness of the case. Most importantly, the donor’s money goes directly to the hospital and not to the patient’s account, this way the treatment is ensured,” he says.

Apart from this, the organisation even gives opportunities to youngsters to play an active part in helping out.

“There are many ways in which youngsters can pitch in too. First and foremost is through social media. The main aim is to get the word out to the possible donors out there and the youngsters can do this with the help of their connections in the social media. They can also help by volunteering, taking part in our street campaigns, content writing and other activities,” says Raghuram. To get in touch with the organisation, one can visit the website: www.righttolive.org or call 40934193.

DH Newsletter Privacy Policy Get the top news in your inbox
GET IT
Comments (+)